The forecast for pancreas malignant neoplasms mortality in the US shows a consistent upward trend from 2024 to 2028, increasing annually from 26.45 thousand male deaths in 2024 to 28.5 thousand in 2028. This data indicates an average annual increase of approximately 1.9% in male deaths related to this disease over these five years. The data from 2023, which serves as the baseline for these forecasts, suggests a continuation of a rising trend in mortality rates.

Future trends to watch include:

Advancements in early detection and treatment that could impact mortality rates.
Public health initiatives aimed at reducing risk factors such as smoking and obesity.
Demographic changes, such as an aging population, which could further influence mortality trends.